First blepharoptosis drug gains FDA approval
- Posted on: Jul 14 2020
- Leave a response
The FDA has cleared a novel ophthalmic solution of oxymetazoline hydrochloride (Upneeq) for acquired blepharoptosis, making it the only approved therapy for the condition.
Source: AAO
Posted in: Uncategorized
